Company Filing History:
Years Active: 2011-2015
Title: Nathalie Durant: Innovator in Vaccine Protection Assays
Introduction
Nathalie Durant is a prominent inventor based in Rixensart, Belgium. She has made significant contributions to the field of vaccine protection, particularly through her work on Serum Bactericidal Activity (SBA) assays for Gram-negative bacteria. With a total of 3 patents, her innovations are paving the way for advancements in vaccine efficacy and safety.
Latest Patents
One of Nathalie's latest patents focuses on a Vaccine Protection Assay. This invention relates to the field of Serum Bactericidal Activity (SBA) assays, which are crucial for measuring the functional activity of serum antibodies against meningococcus. The SBA test is essential for determining whether a subject or population is seropositive against invasive meningococcus. Nathalie and her team have discovered that the standard serotype A and W SBAs can be significantly improved in terms of sensitivity and specificity.
Career Highlights
Nathalie Durant is currently employed at GlaxoSmithKline Biologicals SA, where she continues to innovate in the field of vaccine development. Her work has been instrumental in enhancing the understanding and effectiveness of vaccines against serious bacterial infections.
Collaborations
Nathalie collaborates with esteemed colleagues such as Isabel De Vleeschauwer and Jan Poolman. Their combined expertise contributes to the advancement of research in vaccine protection and public health.
Conclusion
Nathalie Durant's contributions to vaccine protection assays highlight her role as a leading inventor in the field. Her innovative work continues to impact public health positively, ensuring better protection against invasive bacterial diseases.